Blue Note Therapeutics Raises $5.2M in Additional Series A Funding

10 Sep, 2021

Blue Note Therapeutics Raises $5.2M in Additional Series A Funding
Photo by Joanna Kosinska on Unsplash

– Blue Note Therapeutics raised an additional $5.2m in Series A financing, bringing the company’s Series A financing to a total of $31m.
– The financing was provided by Memorial Sloan Kettering Cancer Center (MSK) and Alumni Ventures who joined Series A lead investors JAZZ Venture Partners and Summer VC.
– The additional proceeds will strengthen Blue Note’s capacity to develop evidence-based therapeutics that serve an increasing number of cancer patients.

Health Care Health Diagnostics Medical North America Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: